Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo

European Journal of Pharmacology

Volumn 369, Issue 2, 1999, Pages 175-181

  Bruton, Rachel K ^a   Ge, Jian ^a   Barnes, Nicholas M ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Dopamine release; mGlu receptor, Group I; mGlu receptor, Group II; Microdialysis, in vivo; Striatum, rat

Indexed keywords

1 AMINO 1,3 CYCLOPENTANEDICARBOXYLIC ACID; 2 (2,3 DICARBOXYCYCLOPROPYL)GLYCINE; 3,5 DIHYDROXYPHENYLGLYCINE; ALPHA METHYL 4 CARBOXYPHENYLGLYCINE; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRACEREBRAL DRUG ADMINISTRATION; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOLEUCINE; DOPAMINE; DRUG INTERACTIONS; ELECTROCHEMISTRY; FEMALE; MICRODIALYSIS; RATS; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE; VISUAL CORTEX;

EID: 0033028462     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00072-2     Document Type: Article

References (36)

1. Abbott A., Wigmore M.A., Lacey M.G. Excitation of rat subthalamic nucleus neurones in vitro by activation of a group I metabotropic glutamate receptor. Brain Res. 766:1997;162-167.
2. Barnes N.M., Cheng C.H.K., Costall B., Ge J., Naylor R.J. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride. Br. J. Pharmacol. 107:1992;233-239.
3. Brabet I., Mark S., Bockaert J., Pin J.-P. Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responses. Neuropharmacology. 34:1995;895-903.
4. 1 receptor in vitro and in vivo. Br. J. Pharmacol. 118:1996;414-420.
5. Bruton R.K., Ge J., Barnes N.M. Elevation of in vivo striatal dopamine release in the rat via activation of metabotropic glutamate receptors. Br. J. Pharmacol. 117:1996;. 294 pp.
6. Bruton R.K., Ge J., Barnes N.M. The group I metabotropic glutamate receptor agonist DHPG elevates striatal dopamine release in the rat in vivo. Br. J. Pharmacol. 118:1996;. 73 pp.
7. Bushell T.J., Jane D.E., Tse H.-W., Watkins J.C., Garthwaite J., Collingridge G.L. Pharmacological antagonism of the actions of group II and group III mGluR agonists in the lateral perforant path of rat hippocampal slices. Br. J. Pharmacol. 117:1996;1457-1462.
8. Carrozza D.P., Ferraro T.N., Golden G.T., Reyes P.F., Hare T.A. In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate-evoked striatal dopamine release and effects of antagonists. Brain Res. 574:1992;42-48.
9. Conn P.J., Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Ann. Rev. Pharmacol. Toxicol. 37:1997;205-237.
10. DeLong M. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13:1990;281-285.
11. Desce J.M., Godeheu G., Galli T., Artaud F., Cheramy A., Glowinski J. L-Glutamate-evoked release of dopamine from synaptosomes of the rat striatum: involvement of AMPA and N-methyl-D-aspartate receptors. Neuroscience. 47:1992;333-339.
12. 1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology. 36:1997;265-267.
13. 14C ]-2-deoxyglucose autoradiographic study J. Neurosci. 17:1997;4415-4425.
14. Hayashi Y., Sekiyama N., Nakanishi S., Jane D.E., Sunter D.C., Birse E.F., Udvarhelyi P.M., Watkins J.C. Analysis of agonist and antagonist activities of phenylglycine derivatives for different cloned metabotropic glutamate receptor subtypes. J. Neurosci. 14:1994;3370-3377.
15. Ishida M., Saitoh T., Shimamoto K., Ohfune Y., Shinozaki H. A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord. Br. J. Pharmacol. 109:1993;1169-1177.
16. Javoy-Agid, F., Agid, Y., 1990. Parkinson's disease. In: Riederer, P., Kopp, N., Pearson, J. (Eds.), An Introduction to Neurotransmission in Health and Disease. Oxford Univ. Press, pp. 206-220.
17. Kaatz K.W., Albin R.L. Intrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: a behavioural and fos immunohistochemical study. Neuroscience. 66:1995;55-65.
18. Kingston A.E., Burnett J.P., Mayne N.G., Lodge D. Pharmacological analysis of 4-carboxyphenylglycine derivatives: comparison of effects on mGluR1α and mGluR5a subtypes. Neuropharmacology. 34:1995;887-894.
19. Kosinski C.M., Standaert D.G., Testa C.M., Penney J.B., Young A.B. Dopaminergic neurons in the substantia nigra express a unique splice form of mGluR1. Neurology. 48:1997;A324.
20. Limousin P., Pollak P., Benazzouz A., Hoffmann D., LeBas J.-F., Broussole E., Perret J.E., Benabid A. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet. 345:1995;91-95.
21. Martìnez-Fong D., Rosales M.D., Gòngora-Alfaro J.L., Hernàndez S., Aceves J. NMDA receptors mediate dopamine release in the striatum of unanesthetized rats as measured by brain microdialysis. Brain Res. 595:1992;309-315.
22. Mercuri N.B., Stratta F., Calabresi P., Bonci A., Bernardi G. Activation of metabotropic glutamate receptors induces an inward current in rat dopamine mesencephalic neurons. Neuroscience. 56:1993;399-407.
23. Nicoletti F., Bruno V., Copani A., Casabona G., Knopfel T. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci. 19:1996;267-271.
24. Ohno M., Watanabe S. Persistent increase in dopamine release following activation of metabotropic glutamate receptors in the rat nucleus accumbens. Neurosci. Lett. 200:1995;113-116.
25. Paxinos, G., Watson, C., 1986. The rat brain in stereotaxic coordinates. Academic Press, London.
26. Piallat B., Benazzouz A., Benabid A.L. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur. J. Neurosci. 8:1996;1408-1414.
27. Pin J.-P., Bockaert J. Get receptive to metabotropic glutamate receptors. Curr. Op. Neurobiol. 5:1995;342-349.
28. Pin J.-P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
29. Sacaan A.I., Monn J.A., Schoepp D.D. Intrastriatal injection of a selective metabotropic excitatory amino acid receptor agonist induces contralateral turning in the rat. J. Pharmacol. Exp. Ther. 259:1991;1366-1370.
30. Sacaan A.I., Bymaster F.P., Schoepp D.D. Metabotropic glutamate receptor activation produces extrapyramidal motor system activation that is mediated by striatal dopamine. J. Neurochem. 59:1992;245-251.
31. Schoepp D.D., Goldsworthy J., Johnson B.G., Salhoff C.R., Baker S.R. 3,5-Dihydroxyphenylglycine is a highly selective agonist for phosphoinositide-linked metabotropic receptors in the rat hippocampus. J. Neurochem. 63:1994;769-772.
32. Schoepp D.D., Johnson B.G., Monn J.A. (1S, 3R)-1-Aminocyclopentane-1,3-dicarboxylic acid-induced increases in cyclic AMP formation in the neonatal rat hippocampus are mediated by a synergistic interaction between phosphoinositide and inhibitory cyclic AMP-coupled mGluRs. J. Neurochem. 66:1996;1981-1985.
33. 4 receptor ligands to modulate rat striatal dopamine release in vitro and in vivo. Br. J. Pharmacol. 117:1996;55-62.
34. Taber M.T., Fibiger H.C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. J. Neurosci. 15:1995;3896-3904.
35. Testa C.M., Friberg I.K., Weiss S.W., Standaert D.G. Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia. J. Comp. Neurol. 390:1998;5-19.
36. Wigmore M.A., Lacey M.G. Metabotropic glutamate receptors depress glutamate-mediated synaptic input to rat midbrain dopamine neurones in vitro. Br. J. Pharmacol. 123:1998;667-674.